Indeed, if we suppose that during our study observation period, the incidence of prostate cancer observed in Martinique, which is situated far away from metropolitan France, would have been associated with a less frequent use of PSA test, the results would have been exactly the opposite of what we observed, that is, a lower rate of prostate cancer incidence. The gene discussed is KLK3; the disease is prostate carcinoma.